SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 99 filers reported holding SILVERBACK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.2%.
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SR ONE CAPITAL MANAGEMENT, LP | 4,012,903 | $15,168,773 | 7.77% |
Nextech Invest Ltd. | 1,910,029 | $7,219,910 | 2.19% |
K2 PRINCIPAL FUND, L.P. | 2,552,062 | $9,646,794 | 2.02% |
Charles Schwab Trust Co | 4,246,071 | $16,050,148 | 1.81% |
Sio Capital Management, LLC | 1,105,911 | $4,180,344 | 1.29% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11,077,927 | $41,874,564 | 0.92% |
SECTORAL ASSET MANAGEMENT INC | 1,049,191 | $3,965,942 | 0.77% |
Orbimed Advisors | 9,240,887 | $34,930,553 | 0.74% |
RA Capital Management | 9,459,678 | $35,757,583 | 0.70% |
K2 PRINCIPAL FUND, L.P. | 688,900 | $2,604,042 | 0.55% |
Nantahala Capital Management | 1,099,075 | $4,154,504 | 0.36% |
Tejara Capital Ltd | 103,739 | $392,133 | 0.22% |
TANG CAPITAL MANAGEMENT LLC | 409,463 | $1,547,770 | 0.22% |
Brendel Financial Advisors LLC | 19,125 | $72 | 0.11% |
Rubric Capital Management LP | 639,203 | $2,416,187 | 0.09% |
Clearline Capital LP | 271,678 | $1,026,943 | 0.09% |
Soleus Capital Management, L.P. | 150,000 | $567,000 | 0.05% |
Baker Brothers Advisors | 2,006,451 | $7,584,385 | 0.04% |
Woodline Partners LP | 847,054 | $3,201,864 | 0.04% |
LEVIN CAPITAL STRATEGIES, L.P. | 70,000 | $264,600 | 0.03% |
External links
This page lists SILVERBACK THERAPEUTICS INC's shareholders in Q3 2023. To view SILVERBACK THERAPEUTICS INC's shareholder history, click here.